zur Übersicht: Themendossiers An­ti­bio­ti­ka­re­sis­ten­zen Co­ro­na­vi­rus SARS-CoV-2 Ho­möo­pa­thi­sche Arz­nei­mit­tel Lie­fe­reng­päs­se Me­di­zin­Professional­duk­te Pa­ckungs­bei­la­ge Sta­tis­ti­ken Novartis fought a protracted fight with the government of India over the patenting of its drug, Gleeve